Track Kindly MD, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Kindly MD, Inc. KDLY · Stock Open Kindly MD, Inc. in new tab

11.30 USD
EPS
-0.73
P/B
98.19
ROE
-763.28
Loading chart...
Key Metrics
EPS-0.73
Book Value0.25
Price to Book98.19
Debt/Equity43.58
% Insiders56.120%
Growth
Revenue Growth-0.30%

DCF valuation

Model fair value for Kindly MD, Inc. (KDLY)
Result
Sign in to run the valuation for KDLY.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Kindly MD, Inc. Logo Kindly MD, Inc. Analysis (KDLY)

Is Kindly MD, Inc. a good investment? Kindly MD, Inc. (KDLY) is currently trading at 11.30 USD.

Investor FAQ

Does Kindly MD, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Kindly MD, Inc.?

Kindly MD, Inc. is classified as a Stock.

Company Profile

Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.

Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion